Search results
SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX...
FOX 23 News Albany· 15 hours agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
32 diseases you can catch from animals
Live Science via Yahoo News· 4 days agoSome people don't require treatment for cysticercosis, but it can cause symptoms such as seizures and other side effects in others, in which case...
Assassin Gene Discovery Shifts Cancer Treatment Paradigms – “Very Unexpected Finding”
SciTechDaily· 5 days agoScientists have discovered that the way cancer cells die from chemotherapy appears to be different...
Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating...
Morningstar· 2 days agoThe animals in only the NV-387 treated group survived completely, as previously reported. The complete survival and clear lungs indicate that NV-387 treatment completely protected ...
Congo: Traps, Treaties And Counterterrorism
Strategy Page· 1 hour agoDecember 30, 2021: In Congo investigators continue to probe the so-called “China deal” which was meant to trade Congo minerals for infrastructure projects built by China. China is – or was—supposed ...
From infection to chronic illness: Learning from long COVID
Medical Xpress· 1 day agoWhile there are known links between bacterial and viral infections with post-acute infection syndromes, much is still unknown about the mechanisms that underpin these illnesses or why they occur ...
King County health officer retires after 30-plus years in public health
Seattle Times· 3 days agoDr. Jeff Duchin is accustomed to 100-mile bike rides through the Pacific Northwest mountains, beside...
University of Maryland School of Medicine Launches | Newswise
Newswise· 21 hours agoUniversity of Maryland School of Medicine (UMSOM) researchers at the Center for Vaccine Development and Global Health (CVD) have been awarded $3.96 million to develop a maternal vaccine that ...